Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities (2010 - 2026)

Cumberland Pharmaceuticals has reported Cash from Investing Activities for 17 years, with the latest figure at -$61173.0 in Q1 2026.

• Quarterly Cash from Investing Activities rose 95.02% year-over-year to -$61173.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (down 218.25% YoY) and the FY2025 annual result came in at -$4.7 million, down 8236.82% from the prior year.
• Cash from Investing Activities climbed to -$61173.0 in Q1 2026 per CPIX's latest filing, from -$3.1 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $680805.0 in Q3 2022 and troughed at -$13.5 million in Q1 2022.
• A 5-year average of -$1.1 million and a median of -$95073.0 in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities soared 728.95% in 2022, then slumped 11363.83% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$640772.0 in 2022, then jumped by 140.68% to $260639.0 in 2023, then tumbled by 110.29% to -$26809.0 in 2024, then plunged by 11363.83% to -$3.1 million in 2025, then jumped by 98.01% to -$61173.0 in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$61173.0, -$3.1 million, and -$690837.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.